Sorrento Therapeutics, Inc. short interest in 2018
In 2018, Sorrento Therapeutics, Inc.'s disclosed short interest ran from 4.07% of shares outstanding on 12 Jan 2018 to 16.54% on 31 Dec 2018, a change of +12.47 percentage points. The year's high was 22.49% on 29 Jun 2018 and its low 3.92% on 31 Jan 2018, averaging 14.93% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.81 days on 30 Nov 2018. Full history: Sorrento Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022
2018 in figures
- Start of year
- 4.07% (12 Jan 2018)
- End of year
- 16.54% (31 Dec 2018)
- Change
- +12.47 pp
- High
- 22.49% (29 Jun 2018)
- Low
- 3.92% (31 Jan 2018)
- Average
- 14.93%
- Highest days to cover
- 19.81 (30 Nov 2018)
- SEC filings marked
- 4
Every report in 2018
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2018 | 4.07% | 1.26 | |
| 31 Jan 2018 | 3.92% | 1.00 | |
| 15 Feb 2018 | 4.73% | 1.32 | |
| 28 Feb 2018 | 5.60% | 1.32 | |
| 15 Mar 2018 | 9.36% | 1.78 | |
| 29 Mar 2018 | 13.60% | 2.02 | 10-K filed |
| 13 Apr 2018 | 17.27% | 4.72 | |
| 30 Apr 2018 | 18.92% | 7.73 | |
| 15 May 2018 | 18.00% | 8.44 | 10-Q filed |
| 31 May 2018 | 17.36% | 8.99 | |
| 15 Jun 2018 | 18.44% | 10.50 | |
| 29 Jun 2018 | 22.49% | 5.38 | |
| 13 Jul 2018 | 20.72% | 9.99 | |
| 31 Jul 2018 | 20.37% | 10.40 | |
| 15 Aug 2018 | 16.17% | 16.73 | 10-Q filed |
| 31 Aug 2018 | 16.41% | 18.93 | |
| 14 Sep 2018 | 17.11% | 12.83 | |
| 28 Sep 2018 | 17.46% | 9.60 | |
| 15 Oct 2018 | 16.57% | 11.04 | |
| 31 Oct 2018 | 15.84% | 12.66 | |
| 15 Nov 2018 | 15.57% | 10.63 | 10-Q filed |
| 30 Nov 2018 | 16.22% | 19.81 | |
| 14 Dec 2018 | 15.68% | 12.27 | |
| 31 Dec 2018 | 16.54% | 9.87 |
See also: Sorrento Therapeutics, Inc.'s full history · most shorted US stocks of 2018 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.